Insulet beat first-quarter profit estimates on Thursday, buoyed by strong demand for its wearable insulin pumps, sending shares up 7% in extended trading.

The Insulin Pumps Market is expected to witness a growth rate of 12% by 2028. Increasing prevalence of diabetes, rising ...

Shares of Insulet surged 20% Friday afternoon to lead S&P 500 gainers, a day after the insulin pump maker reported ...

Our first-quarter results showcase the strong execution and dedication of the Insulet team,” said CEO Ashley McEvoy. “I see a ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin patch-pump maker Insulet, as the company seeks to expand its commer | Ashley McEvoy ...

Insulin pump maker Insulet announced announced Ashley McEvoy would replace Jim Hollingshead as chief executive.

McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...

Insulet's sudden leadership change brings a seasoned medical technology executive to the helm, as the insulin pump maker says it expects to exceed Q1 revenue guidance and raise outlook.

Omnipod. Made by Boston-based Insulet, the Omnipod 5 is a tubeless patch pump that provides 3 days of nonstop insulin management. Children and adults can use the Omnipod for both type 1 and type 2 ...

The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

Shares of Insulet (PODD) surged 20% in Friday afternoon trading to pace the S&P 500, a day after the insulin pump maker reported stronger-than-anticipated quarterly results and lifted its full ...